PAMCA Women In Vector Control have organized for a webinar on why gender inclusivity in leadership is important in the elimination of Vector-Borne Diseases.
Kindly register your details here
PAMCA Kenya chapter is organising an all-members plenary webinar. Every individual who identifies with PAMCA Kenya chapter, wishes to be a member of PAMCA Kenya chapter, and works in vector control/Entomology or related field is invited to this webinar. You don’t have to be physically present in Kenya to join or be a member of PAMCA Kenya chapter.
Kindly register your details here
Please see the Panelists and Moderators below
Larval Source Management for Urban Malaria Elimination: The unexploited intervention. How and who to serve it?
PAMCA Zambia and it’s vector control stakeholders invite you for an open forum presentation and discussion on Larval Source Management for Urban Malaria Elimination: The unexploited intervention. How and who to serve it? For more information, please click on the link below to download the informational flyers
Join Zoom Meeting
Meeting ID: 814 4941 8119
MESA Correspondents reporting from the 6th PAMCA Annual Conference
Day 2: Tuesday, 24 September 2019
Plenary session 1.
Dr. Pierre Carnevale (Director of Research Exceptional Class, CE II, France) described a long-term comprehensive vector control project evaluating mosquito control in Balombo area in Angola. The vector control programme evaluated and compared the efficacy of 4 methods: the classical Long-Lasting Insecticide-treated Nets (LLIN) PermaNet® 2, Indoor Residual Spraying (IRS) and two models of the recently developed insecticide-treated plastic sheeting (ITPS). The results suggested that ITPS could usefully replace IRS. It is easier to implement and as efficient as IRS. The data were used to directly inform the national malaria control programme.
To close the gap between communities and their rightful access to healthcare, Brian Gitta (CEO of thinkIT Limited, Uganda) presented Matibabu, an innovative medically non-invasive, cost-effective device for malaria diagnosis that detects malaria in 2 minutes. Matibabu can also assist in disease surveillance management. The prototype has been developed based on users experience.
Dr. Bonventure Savadogo (Swiss TPH) discussed the burden of neglected tropical diseases (NTDs) that affect sub-Saharan Africa and the control approaches used in central Africa. He described achievements in NTD control/elimination so far and highlighted significant achievements made in the control of Human African trypanosomiasis (HAT) and soil-transmitted helminths. He mentioned the shortage of donor funding as a significant challenge towards control and elimination of these diseases. The Swiss TPH recently started a project in collaboration with Organisation de Coordination pour la lutte contre les Endémies en Afrique Centrale (OCEAC) to promote in-country control/elimination of NTDs through capacity building whereby PhD students are trained by experts.
Symposium 2: Strengthening the role of women in
the control of vector-borne diseases
The chair of this session, Dr. Damaris Matoke (KEMRI, Kenya) started an open dialogue on gaps and barriers that limit the participation of women in the control of VBDs. Dr. Theresia Nkia (icipe, Kenya) opened the floor and shared her personal experiences in the field of vector control research in Africa. She mentioned some of the nicknames she was assigned as a woman in vector control to illustrate the challenges that women face. Even though Dr. Matoke indicated that the number of African women holding leadership positions in vector control remains very low, she stressed that women have strong skills and capabilities. Hence, “If you want to get the job done, get a woman to do it.” Afterward, the participants were treated to a “Fireside chat” between Ms Emma Orefua (PAMCA Co-founder and Board Secretary) and Dr Silas Majambere (Director of Scientific Operations, PAMCA secretariat). As the only woman in the PAMCA board for the ten past years, Emma took us on her challenging PAMCA journey. Dr Damaris Matoke (KEMRI, Kenya) gave an overview of the dynamic pre-conference workshop on Women in Vector Control (WIVC). She emphasized how mentorship is the “key” to breaking barriers for women in vector control. This symposium ended with a panel discussion about the role of men in supporting women in research. This discussion was spearheaded by Dr. Neil Lobo (University of Notre-dame, France) and Ms Emma Orefua.
Symposium 3: Target Malaria insectary and field entomology preparedness towards the 1st releases of genetically-modified malaria mosquito Anopheles gambiae s.l.
The Target Malaria’s insectary and field entomology preparedness in Burkina Faso, Mali, and Uganda were the focus of this symposium. Prof Frederic Tripet (Keele University, UK) introduced the symposium by briefly describing the Target malaria project, its objectives and the stakeholders involved.
Dr. Jonathan Kayondo (Target Malaria, Uganda Virus Research Unit (UVRI)) discussed the construction of a new arthropod containment level 2 (ACL-2) facility. The technology and development processes associated with genetically modified (GM) mosquito research need to take place in appropriate contained laboratories. The work in Uganda is still in its early stages, and there is a need to establish good practices. The new insectary incorporates a series of barriers that prevent mosquitoes from escaping. Appropriate cages, double closing doors, access restrictions, sealed windows, modified sinks and drains to prevent the escape of eggs; and the monitoring of escaping insects are all requirements of an ACL-2 facility.
Mr. Moussa Namountougou (Target Malaria, Institut de Recherche des Sciences de la Santé, Burkina Faso) talked about the development of optimized rearing protocols for the maintenance of colour variants and genetically-modified An. gambiae s.l. strains in Burkina Faso. Major facility renovations, development of Standard Operating Procedures for risk management, staff training, and audits took place in preparation for a field release of GM mosquitoes. Mr Namountougou indicated that colour-variant backcrossing is the most critical activity in rearing genetically-modified mosquitoes. Rigorous planning and preparation of the insectary ultimately facilitated the authorization from Burkina Faso authorities for sterile male shipment, and ultimately a permit to allow the field release.
Prof Tripet described Target malaria’s stepwise approach to improve the release of genetically modified male mosquitoes. He highlighted the value of mark-release recaptures as a method to estimate the impact and improve the design and processes of future field releases.
Dr. Florian Noulin (Keele University, UK) gave a presentation about the development of medium-throughput assays for post-release monitoring of GM mosquitoes. Individual and manual techniques can take a lot of time, and a more efficient technique is needed. Dr. Noulin discussed several methods to speed up the analysis, such as pooling mosquitoes, novel mosquito grinding methods and loop-mediated isothermal amplification (LAMP).
Parallel session 4: Innovations in vector surveillance and control
Carmène S. Ngadjeu (OCEAC, University of Yaoundé 1, Cameroon) assessed how improved houses could limit the human-mosquito contact and help to reduce disease transmission. She suggested that the promotion of improved housing needs to be integrated into the malaria control strategy of the city of Yaoundé. Piameu Michael (OCEAC, Cameroon) delivered a talk on the LabDisk diagnostic tool – an automated, cost-effective diagnostic platform for improving vector surveillance. Validation of the tool is currently on-going in four African countries: Cameroon, Ethiopia, Zambia, and Ivory-coast.
John Lucas (Sumitomo Chemical Company) encouraged the use of Sumishield 50WG, prequalified by WHO in 2017, as a new insecticide for IRS. Sumishield is currently being used extensively throughout Africa, and studies indicate widespread field susceptibility against Anopheles mosquitoes. Michael Coleman (Liverpool School of Tropical Medicine, UK) gave a presentation on the development of a handheld device for quality assurance of IRS. This tool is yet to undergo a final field validation.
Yacouba Poumachu (OCEAC, Cameroon) described how a genetic sexing strain (GSS) has helped the mass production of An. arabiensis. Cytogenetics investigation of this strain is needed before the implementation of large-scale sterile insect technique (IST) programmes. The presentation by Elijah Juma (University of Illinois, US) focused on the impact of pesticides on the gut microbiota of mosquitoes (Culex pipiens L.). He discussed promising results showing that mosquito bacterial community composition is influenced by mosquito life stages and the immediate environment, but not by pesticide treatments.
Elias Miyituma (Rwanda Biomedical Center, Rwanda) explained that in the project study sites in Rwanda, An. arabiensis was the dominant species in the IRS sites because of its preference to feed on cattle rather than on humans. On the other hand, An. gambiae was found to be the primary vector in sites where IRS was not deployed. In areas where An. arabiensis is becoming the dominant malaria vector, regular treatment of cattle with insecticides could provide additional protection against malaria.
Parallel session 5: Adopting the One Health approach – breaking down silos
Ellie Sherrard-Smith (Imperial College, UK) presented about the benefits of larval source management for pyrethroid resistance. She also described the role of community engagement programmes that encourage environmental management to reduce mosquito populations. She further gave an account of how this method was successful in eliminating malaria in large parts of the world in the past. Tovi Lehmann (National Institutes of Health, NIH, USA) gave a presentation about the potential role of long-distance windborne vector migration in the spread of arboviruses. He reported a study where insects flying between 40 and 290m above ground level were sampled using sticky traps attached to helium balloons. The results suggested mean nightly migrations of up to 300km for 9-hour flight durations. The findings of this study have important implications for control and sampling methods.
Miss Fatou Fofana (RHD-LRR, The Gambia) talked about schistosomiasis, an acute and chronic disease. Common control methods include mass drug administration, health education, and environmental sanitation. Fofana summarised the prevalence of schistosomiasis in Minna community, Jarra central district in the Gambia before and after a health education campaign in 2014. Rousseau Djouaka (University of Abomey, Benin) described a study about the link between agriculture and malaria transmission. His results show that λ-Cyhalothrin, a widely used insecticide by farmers in Benin, degrades in the environment and does not play a significant role in resistance selection in An. coluzzii populations. Additionally, copper residues present in breeding sites may be correlated with insecticide resistance evolution of malaria vectors.
Richard Oxborough (Abt Associates, USA) presented on behalf of Francis Wat’senga (Institut National de Recherche Biomédicale, DR Congo). He presented results from a nationwide study about pyrethroid resistance in mosquito populations at 11 study sites in DRC. Moderate and high-intensity resistance was recorded in several provinces using the WHO tube tests and CDC bottle assays. A widespread pyrethroid resistance to all the three pyrethroids (deltamethrin, alpha-cypermethrin, and permethrin) that are used on LLINs in DRC was reported. He recommended the use of next-generation nets (PBO or bi-treated nets) in DRC as an alternative to the pyrethroid insecticides.
Symposium 4: Vector control innovations to drive progress in malaria and other mosquito-borne disease control
This symposium focused on innovation in vector control tools and approaches for both Anopheles and Aedes control. Early findings of the scaling-up of new tools and the respective decision-making processes for malaria programs were also discussed.
Derric Nimmo (Innovative Vector Control Consortium, IVCC, UK) kicked off the symposium by explaining the role of IVCC as a product development partnership that helps companies and other innovators to the deliver and develop novel insecticides and tools for vector control. He discussed several novel vector control tools, expressing a particular interest in attractive targeted sugar baits (ATSB) with reference to a multi-country trial currently taking place in sub-Saharan Africa. Ingrid Etoke (IVCC, UK) presented the New Nets Project, a partnership that aims to accelerate access to next-generation nets that use novel active ingredients. Access to these new resistance-breaking LLINs can be restricted by insufficient evidence to support policy recommendations and a lack of evidence on cost-effectiveness. Derric Nimmo described 2 cluster-randomized trials in Tanzania and Benin assessing three novel LLINs, with hut trials taking place alongside to establish entomological surrogates. Datasets from these trials will feed into a broader analysis of the cost-effectiveness of dual LLINs.
Andrew Saibu (IVCC, UK) presented the early results of the PMI VectorLink rollout of 3rd generation IRS (3GIRS) insecticides, Fludora Fusion, and SumiShield, as part of the NgenIRS project. NgenIRS is a 4-year Unitaid funded project that aims to increase the use of 3GIRS products in insecticide resistance management programmes. Richard Oxborough (Abt Associates, USA) later described new neonicotinoid-based IRS formulations that resulted in high mortalities in malaria vectors in Burkina Faso, Ghana, Madagascar, Mali, Mozambique, and Zambia.
Silas Majembere (Mosquito Consulting, Norway) described a spatial intelligence system for precision larviciding using drones and google earth engine. This system addresses some challenges associated with applying larviciding. The technology was trialed in Zanzibar in hotspots identified using routine malaria surveillance data. Phone-based weekly reporting was used to identify, access and monitor water bodies.
Eric Ochomo (Kenya Medical Research Institute, KEMRI, Kenya) discussed the results of a randomised controlled trial investigating high-dose ivermectin for malaria elimination (IVERMAL). The results suggested that ivermectin is a promising novel tool for malaria control that effectively kills mosquitoes that recently fed on human blood that contains ivermectin.
Lina Finda (Ifakara Health Institute, Tanzania) discussed the potential of eave ribbons as a complementary vector control intervention for low-income households. There are many cases in which IRS and LLINs are not sufficient for elimination. Ribbons are soaked in transfluthrin and placed in the eave spaces. Finda presented the results of an enclosed semi-field system study that indicated the potential for eave ribbons to protect against both indoor and outdoor malaria vectors.
Symposium 5: Enhancing entomological capacity in Africa for effective vector-borne disease control: prospects, challenges, and opportunities
In Africa lack of capacity to respond timely and effectively to increased VBD transmission is a major factor that aggravates the threat posed by these diseases.
Kevin O. Opondo (Medical Research Council Unit, London School of Hygiene and Tropical Medicine, The Gambia) gave a talk (on behalf of Fredros Okumu, IHI Tanzania) on ten barriers and ten practices for creating a productive ecosystem to support early-career health researchers in Africa. “Research leaders and administrators have the duty to create an enabling environment for early-career scientists so that they can effectively address priority health needs on a sustainable basis”. Abdoulaye Diabate (IRSS, Burkina Faso) spoke about how to enhance entomological research capacity in sub-Saharan Africa. He also provided an overview of the future prospects of the ITECH-MTV Center of Excellence (ACE) in Burkina Faso. The final presentation was by Chadwick H. Sikaala and Lesley-Anne van Wyk (SADC Malaria Elimination 8 Secretariat). The duo gave an overview of the E8 Entomology Fellowship, a 5-steps program meant to equip young scientists from the southern African region with the dexterity to effectively support malaria control programs. Two of the E8 fellows also shared their personal experience on the dividends of participating in the fellowship.
Strengthening surveillance systems for vector-borne disease elimination in Africa
Day 1: Monday 23 September 2019
Dr. Antonio-Nkondjio Christophe (Organisation de Coordination pour lalutte contre les Endémies en Afrique Centrale, OCEAC) chair of the local organizing committee, opened the stage of this 6th Pan-African Mosquito Control Association (PAMCA) Annual Conference organized for the first time in Yaoundé, city of 7 mountains, Cameroon, Central Africa. As Africa alone accounts for 40% of the world’s burden of vector-borne diseases (VBDs), Dr Christophe emphasized the need to break down the deadly cycles of these diseases as one of the prerequisites to achieve economic prosperity in Africa. This conference provides a platform to enable the exchange of knowledge, capacities, and actions and face the challenges to foster the elimination of VBDs in Africa.
PAMCA president Prof Charles Mbogo (Kenya Medical Research Institute, KEMRI, and University of Nairobi, Kenya) expressed a very warm welcome to all conference participants and took the opportunity to recapture the PAMCA vision of an “Africa free of vector-borne diseases.” With about 350 participating delegates, this 3-day event follows two pre-conference workshops: the Gene Drive Technology Training Course and the Women in Vector Control Workshop. These workshops served to equip young African scientists, especially women, with effective tools to enable them to play their rightful role in the control of VBDs in Africa. Prof Mbogo concluded that
“one of the key drivers of PAMCA is to comprehensively develop vector surveillance in one voice, in one action to combat vector-borne diseases – we do not want to continue working in isolation, but in unison.”
James Newell spoke on behalf of Dr. Prosper Chaki, PAMCA Executive Director, and reminded the audience of the necessity to build entomological capacities, robust systems and to use appropriate management systems that can enable the African continent to respond effectively to VBDs.
Dr. Phanuel Habimana (WHO Cameroon Representative) emphasized the tremendous burden imposed by VBDs that account for over 435 000 annual deaths in Africa with malaria-causing the highest burden.
Finally, Dr. Manuel-Nso Obiang (OCEAC Executive Director) presented OCEAC’s facilities and its technical platform. These assist central African countries in their fight against infectious and vector-borne diseases through health policy development, research and training, and health emergency management and responses.
After being treated to a taste of the Cameroonian cultural dance by the University of Yaounde musical group, Prof Joseph Lebel Tamesse, the representative of the Minister of State Higher Education, presided over an award ceremony to recognize 15 outstanding scientist/researchers. This was followed by a group photo, a stunning musical performance, and an official opening address by Prof Tamesse.
Prof Charles S. Wondji (Executive Director, Centre for Research in Infectious Diseases (CRID), Liverpool School of Tropical Medicine, UK)highlighted the current challenge of genomic evolution of insecticide resistance facing pyrethroid-based interventions of malaria vectors. He cited over-reliance on a single class of insecticides, the pyrethroids, as a major cause of resistance that necessitates the diversification of control tools and strategies. He further emphasized the need for molecular markers for the detection of insecticide resistance in the major malaria vectors in Africa (An. gambiae and An. funestus). Additionally, the operation of resistance management strategies early enough will help to manage the spread of insecticide resistance. New approaches are also needed beyond IRS and LLNs to reduce malaria transmission, for instance, genetic approaches such as CRISPR-cas9 and gene drives; and capacity development through training of the next generation of African researchers on mosquito-borne diseases control.
The opening session was also graced by the presence of Rodger Milla, the PAMCA goodwill ambassador. Mr. Milla is a former Cameroonian footballer, and his passion for malaria stems from his personal experience as a victim of the malaria scourge.
Plenary session 1.
Prof Yeya Touré (Retired from WHO/TDR and Malaria Research & Training Centre (MRTC), Mali) mentioned the lack of progress in malaria control in recent years in general and the vector control challenges with respect to achieving malaria elimination, in particular: to achieve high ITN/LLINs and IRS coverage, and to address insecticide resistance that is spreading across Africa. Prof Touré explained that, in 2016, the WHO identified 21 countries with the potential to eliminate malaria by 2020, christened the E-2020 goal. Currently 11 of these countries are on track to achieve elimination, but ten countries are off-track. The WHO adopted a new “high burden to high impact” approach that complements the E-2020 goal. In concluding, he highlighted the need to optimize current vector control strategies, strengthen integrated vector surveillance and enhance multi-sectoral collaboration to move closer towards malaria elimination.
Dr. Didier Fontenille (Institut de recherche pour le développement, IRD, France) took the participants through mosquito biology, ecology, and control. Particularly, he focused on dengue fever viruses and the Plasmodium parasite; these pathogens are transmitted by vectors that have different genetic structure. As such, it is difficult to use one control strategy to target all the vectors. Effective mosquito vector control should, therefore, take into consideration different ecological settings, evolution and public health risk. He challenged participants to think globally and act locally.
Prof Hillary Ranson (Liverpool School of Tropical Medicine, UK) provided an overview of the current status of malaria burden in Burkina Faso. This country still bears a high malaria burden despite high coverage and use of bed nets. A longitudinal study in Burkina Faso reveals presence of pyrethroid resistance and poor health-seeking behavior of adults. The highlight of the talk was the need for a multidisciplinary approach in malaria control.
Parallel session 1: Harnessing research capacity in Africa to empower national programs
Agapitus Kato (Ministry of Health Uganda, Uganda Virus Research Institute) demonstrated how the design of cost-effective and scalable implementation systems for larviciding policies could reduce malaria transmission in Uganda, especially in large populations.
Jessy Marlene Goupeyou-Youmsi (University of Malawi) talked about the susceptibility of Anopheles mosquitoes to Plasmodium falciparum and Plasmodium vivax infections in Madagascar. Her work demonstrated the need to monitor P. vivax infections in clinics and mentioned the potential for vector control to prevent both P. falciparum and P. vivax infections.
Elodie Vajda (University of California San Francisco) discussed a novel Entomological Surveillance Planning Tool (ESPT) to improve vector-control decision-making. This tool provides national malaria programs with a decision framework for entomological surveillance planning, analysis of entomological data, and for measuring human behavior associated with vector behaviour.
Mutale Chisanga (Macha Research Trust, Zambia) showed how a reference laboratory that offers entomological services to other research institutes enabled Zambia to successfully support programmatic operations in the area of entomological surveillance.
Aurelie Prisca Yougang (University of Yaoundé 1, Cameroon) presented a study about the susceptibility profile and mechanisms involved in insecticide resistance in populations of Aedes albopictus in Cameroon.
Efundem Agboraw (Liverpool School of Tropical Medicine) discussed a systematic review of the cost and cost-effectiveness of malaria control strategies and related health outcomes.
Parallel session 2: Mosquito genomics: progress and challenges
Nsa Dada (CDC, USA, KEMRI, Kenya) talked about microbiota-mediated insecticide resistance. Dada’s study demonstrated significant differences in the bacterial composition and putative enzymes of resistant vs. susceptible mosquitoes.
Flore M. M. Kouamo described a study outlining the role of GST genes in conferring resistance to pyrethroids/DDT.
Tony Nolan (Liverpool School of Tropical Medical, UK) described a study detailing an improvement to the CRISPR-Cas 9 gene drive system, a mosquito genetic control that is being explored for mosquito population suppression and population replacement strategies.
Thabo Mashatola (National Institute for Communicable Diseases of the National Health Laboratory Service, South Africa) talked about a review of the progress of sex-separation techniques for sterile insect technique (STI) application against Anopheles arabiensis.
Alistair Miles’ (The An. gambiae 1000 genome consortium) presentation focused on the An. gambiae genome, specifically looking at single nucleotide polymorphisms (SNPs) and copy number variations (CNVs). Interestingly, Cytochrome P450 gene cluster is a CNV hot spot. Also, he explained how these genes can be exploited for surveillance/insecticide resistance management.
David Weetman (LSTM, UK) then talked about gene duplication and selection and how these processes can drive the spread of organophosphate resistance in African An. gambiae.
Keith R. Hayes (The Commonwealth Scientific and Industrial Research Organisation, CSIRO, Australia) provided insights on risk assessment (e.g. effect on target organism, spread, and persistence, horizontal gene transfer) with respect to genetic control methods for malaria vectors.
Symposium 1: Guidance on stakeholder engagement
principles to inform the development of area-wide vector control methods
New vector control approaches have led to a renewed focus on stakeholder engagement and consent. Area-wide interventions require a community-based approach
Delphine Thizy (Imperial College London, UK) discussed the importance of responsible and thorough stakeholder engagement during the R&D process.
Lina Finda (Ifakara Health Institute, Tanzania) and Damaris Matoke-Muhia (Research Scientist, KEMRI, Postdoctoral Fellow, ICIPE, Kenya) discussed the need for alternative and supplementary strategies.
Lea Pare Toé (Institut de Recherches en Sciences de la Santé, IRSS-Burkina Faso) explained the seven years community engagement with a release project of sterile male mosquitoes in Burkina Faso through step-by-step engagement, inclusive engagement, and transparency in the research.
Parallel session 3: Vector biology and control
Caroline W. Kiuru (Max plank Institute for Infection Biology, Germany) talked about the role of bacteria in mosquito growth and development. Using different E. coli mutants, she highlighted two different pathways that influence mosquito larvae development.
Etienne Fondjo (Abt Associates, Cameroon) described how he used different approaches to assess insecticide resistance intensity in An. Gambiae. His work focused on four sentinel sites in Cameroon and selection of these sites were based on malaria transmission levels.
Delenasaw Yewhalaw (Jimma University, Ethiopia) focused on pyrethroid resistance in malaria vector populations in Ethiopia. From his findings, he suggests that Pyrethroid-PBO nets should be incorporated in areas with pyrethroid-resistant mosquito populations.
Kenyssony Valera (Abt Associates, Mozambique) presented a study conducted in Mopeia, Mozambique evaluating the impact of a third-generation IRS. The use of this product resulted in a reduction of An. funestus, both outdoor and indoor.
Theresia Nkya (ICIPE, Kenya) presented the experimental design of a project that assessed the feasibility and impact of community-based winter larviciding on malaria transmission in Namibia, Botswana, and Swaziland.
This report is brought to you by MESA Correspondents Nathalie Amvongo Adija (Institute of Medical Research and Medicinal Plants Studies, Cameroon), Joanna Furnival-Adams (Liverpool School of Tropical Medicine, UK), Trizah Koyi (International Centre of Insect Physiology and Ecology, Kenya) and Teresia Njoroge (University of Illinois at Urbana-Champaign, USA) with mentoring and editorial support from MESA and MalariaWorld. Senior editorial support has been facilitated by Elijah Juma & Silas Majambere from PAMCA. This report is cross-posted on the MESA Website and on MalariaWorld.